Data / Form D filings / SymbioCellTech, LLC
SymbioCellTech, LLC: Form D filings
SymbioCellTech, LLC, a biotechnology company in Salt Lake City, UT, filed 4 Form D notices with the SEC between 2014 and 2017. The latest, on August 28, 2017, reports $286,050 sold of a $2 million offering to 3 investors.
Find out what SymbioCellTech, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 615 ARAPEEN, SUITE 210, Salt Lake City, UT, 84108
- Phone
- (801) 503-3990
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Utah
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1575304
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28, 2017 | New notice | $2,000,000 | $286,050 | $1,713,950 | 3 | Aug 14, 2017 | sec.gov |
| Jun 30, 2016 | New notice | $2,000,000 | $1,912,600 | $87,400 | 4 | Jun 20, 2016 | sec.gov |
| Jun 5, 2014 | Amendment | $7,000,000 | $2,555,000 | $4,445,000 | 7 | Mar 17, 2014 | sec.gov |
| Mar 21, 2014 | New notice | $2,000,000 | $200,000 | $1,800,000 | 2 | Mar 17, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Allen Gardner | Director | |
| Phil Holmes | Director | |
| Axel Zander | Director, Promoter | |
| Susan McKeever | Executive Officer, Director | |
| Robert Maddock, LLC | Director | |
| Christof Westenfelder | Executive Officer, Director, Promoter | |
| Anna Gooch | Executive Officer, Director | |
| George Reiss | Director |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 14 LLC offering · Nov 9, 2026
- Life Impact Partners 15 LLC offering · Nov 9, 2026
- Life Impact Partners 7 LLC offering · Nov 6, 2026
- Life Impact Partners 6 LLC offering · Nov 6, 2026
- Life Impact Partners 3 LLC offering · Nov 6, 2026
- Life Impact Partners 5 LLC offering · Nov 6, 2026
- Life Impact Partners 4 LLC offering · Nov 6, 2026
- Life Impact Partners 2 LLC offering · Nov 6, 2026
- Life Impact Partners 8 LLC offering · Nov 6, 2026
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Aug 28, 2017 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SymbioCellTech, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.